Start here if you're new
what it is
QuantumScape is trying to sell a new kind of EV battery that charges faster and stores more energy.
how it gets paid
Last year Quantumscape made $50M in revenue. PowerCo royalty payment was the main engine at $19.5M, or 100% of sales.
what just happened
QuantumScape reported a -$0.17 Q4 loss per share, missed the -$0.16 consensus, and still showed its first $19.5M royalty payment.
At a glance
C+ balance sheet — struggling to keep the lights on
45/100 earnings predictability — expect surprises
11.0% return on capital — nothing to write home about
xvary composite: 18/100 — weak
-$0.55 fy2027 eps est
What they do
QuantumScape is trying to sell a new kind of EV battery that charges faster and stores more energy.
The moat is not sales yet. It is Volkswagen owning 26.2% of the company and already sending a $19.5 million royalty payment through PowerCo. If you are an automaker, you do not spend your time testing 24-layer cells unless your charging time and range math might improve.
How they make money
$50M
annual revenue
PowerCo royalty payment
$19.5M
new
Prototype cell shipments
$0
flat
Pilot-line manufacturing
$0
flat
Other applications
$0
flat
The products that matter
battery technology platform
Battery platform
$50M annual revenue
this is the whole economic story on the page: $50M in annual revenue supporting a ~$4B valuation.
commercialization bet
energy density proposition
Better energy density
$2B fy2029 rev est
this is the promise behind the valuation. the long-range revenue view reaches $2B by fy2029, which is why investors tolerate only $50M today.
future matters more than present
battery life proposition
Longer battery life
-$0.55 fy2027 eps est
the technical pitch still has to outrun the losses. if EPS is still -$0.55 in fy2027, commercialization has more proving left to do.
execution watch
Key numbers
$19.5M
first royalty
This is the first real money attached to the battery story, which matters more than another lab milestone.
26.2%
Volkswagen stake
A global automaker owns more than a quarter of the company, which tells you this is more than a science fair project.
-$0.76
2025 EPS
Losses improved from -$0.94 to -$0.76, but you are still funding a company that burns cash before it earns it.
2.1
beta
Beta → how violently a stock moves versus the market → so what: QS tends to swing twice as hard as the index.
Financial health
C+
strength
- balance sheet grade C+ — weak — may struggle to fund operations
- risk rank 5 — safer than 5% of stocks
- price stability 5 / 100
- long-term debt $29M (1% of capital)
- net profit margin 12.3% — keeps 12 cents of every dollar in revenue
- return on equity 11% — $0.11 profit for every $1 investors have put in
C+ — below average. watch for debt servicing and cash burn.
Total return vs. market
You invested $10,000 in QS 3 years ago → it's now worth $7,100.
The index would have given you $13,880.
source: institutional data · total return
What just happened
missed estimates
QuantumScape reported a -$0.17 Q4 loss per share, missed the -$0.16 consensus, and still showed its first $19.5M royalty payment.
The quarter was a mix of progress and pain. EPS improved from four straight 2024 quarterly losses between -$0.24 and -$0.22, but the business still closed 2025 with a full-year loss of -$0.76 per share.
$19.5M
q4 royalty payment
-$0.17
q4 eps
$435.1M
fy2025 net loss
the number that mattered
The number that mattered was $19.5 million because it was the first paid sign that a customer relationship is turning into money.
-
quantumscape closed 2025 in the red.the company has yet to commercialize a product, and research and development (r&d) spending, along with elevated operating costs, remained high, as the battery maker ramped up its cobra production process to prepare qse-5 cells for customer shipments.
-
therefore, fourth-quarter and full-year per-share losses came in at $0.17 and $0.76, respectively.
-
even so, the company made encouraging progress toward commercialization.quantumscape transitioned from its older raptor process to the more advanced and efficient cobra platform, which should support gigawatt-hour-scale production within the facilities of its licensing partners. following this shift, quantumscape shipped cobra-based qse-5 cells to the volkswagen group and other automotive partners. the technology was also showcased in the ducati v21l electric racing motorcycle, demonstrating the power capabilities of its solid-state cells.
-
the company received its first royalty payment of $19.5 million from vw’s powerco in the fourth quarter, which was recorded in shareholders’ equity.in addition, partnerships with corning and murata manufacturing strengthen its supply chain, particularly for ceramic separators, a key component of its battery architecture.
-
management intends to advance the capital-light strategy further.the newly launched eagle line, in early february, utilizes the cobra process, which is roughly 25 times faster than its predecessor, and will support customer sampling and validation of qse-5 cells. the goal is to demonstrate scalability through improved output and flexibility across applications, while moving automotive partners through successive development and licensing stages. moreover, expansion of the solidstate battery technology into adjacent high-value markets, such as consumer electronics and drones, remains under consideration.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
the #1 risk is commercialization delay in next-generation batteries — QS has only $50M of annual revenue today, so the future is doing most of the valuation work.
high
commercialization slips and the $2B fy2029 story starts looking far away
the gap between $50M of current revenue and $2B of long-range revenue is the entire bull case. if scale comes later than expected, the valuation has less to stand on.
current revenue is $50M. the long-range expectation is $2B.
high
shareholder litigation stays part of the story
the investor class action remains a credibility drag. early-stage companies can survive lawsuits, but they do not need extra reasons for investors to doubt the story.
this is a trust risk on top of an already speculative setup.
high
funding pressure if losses persist longer than expected
a C+ balance sheet and expected EPS of -$0.55 in fy2027 leave less room for operational delays. low debt at $29M helps, but it does not remove the need for commercial traction.
5 / 100 price stability means the stock does not absorb bad news gently.
with only $50M of revenue today and a speculative path to $2B by fy2029, the downside is mostly timeline risk wearing different costumes.
source: institutional data · regulatory filings · risk analysis
Pay attention to
metric
$50M revenue versus a ~$4B valuation
this gap is the whole setup. if revenue does not start closing it, the stock stays narrative-heavy.
trend
3 straight quarters of institutional net buying
163 buyers versus 112 sellers in 4q2025 says money managers are still interested. you want to see that support persist.
risk
the class action and credibility overhang
speculative stories need trust. legal noise makes it harder for the market to give management the benefit of the doubt.
calendar
fy2027 EPS still sits at -$0.55
the next big checkpoint is whether losses narrow on the way to the fy2029 revenue vision. if not, the timeline is slipping.
Analyst rankings
earnings predictability
45 / 100
in human-speak, analysts do not trust the earnings path to be smooth.
price stability
5 / 100
this stock moves like a speculative project, not a mature operating company.
risk profile
5
a 5 risk rank is the system telling you the downside is real if execution slips.
source: institutional data
Institutional activity
institutions have been net buying for 3 consecutive quarters — 163 buyers vs. 112 sellers in 4q2025. total institutional holdings: 0.2B shares. net buying for 3 quarters.
source: institutional data
Price targets
3-5 year target range
$2
$10
$7
current price
$6
target midpoint · 12% from current · 3-5yr high: $16 (+135% · 24% ann'l return)
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive